Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02516553
Title BI 894999 First in Human Dose Finding Study in Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10021 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Brussels - HOSP Jules Bordet Anderlecht 1070 Belgium Details
Brussels - UNIV Saint-Luc Bruxelles 1200 Belgium Details
UNIV UZ Gent Gent 9000 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
HOP Timone Marseille 13385 France Details
HOP Hôtel-Dieu Nantes 44000 France Details
HOP Saint-Louis Paris 75475 France Details
INS Gustave Roussy Villejuif 94800 France Details
Universitätsklinikum Tübingen Tübingen 72076 Germany Details
Samsung Medical Center Seoul 06351 Korea, Republic of Details
Hospital Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field